 | Dyne Therapeutics, Inc. | |||
| NMS : DYN || Location: United States | ||||
$25.44+0.57 (+2.29%) |
0.79 M | 24.83 - 26.33 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 8.077 M |
| March 15, 2024 | 6.823 M |
| Feb. 29, 2024 | 6.610 M |
| Feb. 15, 2024 | 7.248 M |
| Jan. 31, 2024 | 8.555 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.93 | -1.09 | -17.74% |
| 09/30/2023 | -0.84 | -0.99 | -17.75% |
| 06/30/2023 | -0.82 | -1.08 | -32.42% |
| 03/31/2023 | -0.78 | -0.78 | -0.46% |
| 12/31/2022 | -0.85 | -0.74 | 13.30% |
DYN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 86.178M | Shares Float | 52.675M |
| Short Float | 8.077M | Market Cap | 2143.25M |
| Institution ownership | 87.98% | Insider ownership | 0.554% |
| Earnings Date | 05/01/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.95 | Forward EPS | -3.27 |